Status:
UNKNOWN
The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms
Lead Sponsor:
University of Calgary
Conditions:
Chronic Sinonasal Symptoms
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Chronic sinonasal symptoms (CSNS), such as coughing, throat clearing, nasal obstruction, crusting, dryness and discharge are extremely common in the general population. Although the physical symptoms ...
Eligibility Criteria
Inclusion
- one or more the following symptoms: nasal stuffiness, nasal dryness or crusting, nasal congestion, discolored nasal discharge, or thick nasal discharge, for four or more days a week in the preceding two weeks
Exclusion
- poorly controlled asthma
- cystic fibrosis
- chronic obstructive pulmonary disease (COPD)
- severe coronary artery disease
- vasculopathy
- poorly controlled diabetes
- poorly controlled hypertension
- women who are breastfeeding
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00866866
Start Date
March 1 2009
End Date
May 1 2010
Last Update
March 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada